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Abstract: People with some occupational or recreational activities, such as hunters and veterinarians,
may have increased risk to be infected by the hepatitis E virus (HEV). The aim of the present study
was to establish whether forestry workers could be considered at a higher risk of HEV infection than
a control group. One hundred and fifty sera from forestry workers and a control group of 85 sera
were analysed by anti-HEV IgG antibodies detection using a commercial ELISA kit. The anti-HEV
IgG seroprevalence was 14% for forestry workers and 9.4% for the control group. Comparing
the risk of HEV infection in the two groups, there was no difference in the odds ratio. However,
the seroprevalence in older subjects was higher in the forestry workers than in the control group.
Two sera from forestry workers were also positive for anti-HEV IgM, and, in one of them, HEV-RNA
was detected. Our findings showed an increase of seroprevalence with age, which is likely to reflect
cumulative exposure to HEV over time. The occupation of forestry workers did not seem to be
associated with a higher risk of HEV infection. The study provided new insights into the risk of
acquiring HEV in occupational exposure workers with open-air activities.
Keywords: hepatitis E virus; anti-HEV IgG seroprevalence; forestry workers; occupational risk
1. Introduction
Hepatitis E is an acute viral disease caused by the hepatitis E virus (HEV), transmitted by
the faecal-oral route [1]. Generally, the infection is self-limiting, but it can become chronic in
immunosuppressed patients [1]. HEV is a quasi-enveloped [2], positive-stranded RNA virus coding
for three open reading frames (ORF1–3). The virus is classified in the family Hepeviridae. This family
has been divided into the genera—Piscihepevirus and Orthohepevirus [3]. The genus Orthohepevirus is
divided into four species (A–D) [4].
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Strains affecting humans belong to five genotypes of Orthohepevirus A: HEV-1–4 and HEV-7.
Genotypes HEV-1 and HEV-2 are restricted to humans; genotypes HEV-3 and HEV-4 circulate in
developed countries and are zoonotic, with pigs and wild boar as the main reservoirs [5]. Genotype
HEV-7 has been detected in dromedary camels and one human case [6,7].
In Europe, the disease is linked to HEV-1 and HEV-2 for subjects travelling in low-income countries,
and, in the last years, an increasing number of autochthonous cases due to HEV-3 and HEV-4 have
been described. The main route of HEV-3 and HEV-4 transmission is foodborne by the consumption
of raw or undercooked pork and wild boar meat [8,9]. Several studies have also suggested that
working exposures to pigs or wild boar may represent a risk to be infected by HEV. A higher HEV
IgG seroprevalence has been reported in veterinarians working with swine (9.6%) [10], pig farmers
(14.1%) [11], abattoir workers (28.3%) [12], hunters (22.2%) [13] and forestry workers (18.0%) [14].
In Italy, the consumption of raw or undercooked wild boar meat and pork products containing the
liver has been associated with an increased risk of HEV infection [15]. Furthermore, HEV seropositivity
has been significantly associated with occupational exposure to pigs (12.3%) [11].
In Italy, the anti-HEV IgG antibodies seroprevalence in blood donors vary between 1% and 10%,
and, in Trentino-Alto Adige region, an area in Northern Italy with a mostly mountainous territory, it is
4.5% [16].
In the Italian wild boar populations, HEV infection is common, and the mean seroprevalence
ranges from 4.9% [17] to 56.2% [18]. The infection in other wild animal species has been rarely
investigated, but two studies conducted on red deer have confirmed the circulation of HEV-3 with
seroprevalence values ranging from 1.2% [19] to 13.9% [20], and to a lesser extent (0.8%) also in
chamois [19]. In the present case-control study, the seroprevalence of anti-IgG HEV antibodies in
forestry workers (exposed group), in contact with wild animals and in a control group, was investigated,
in order to evaluate the potential risk linked to professional activities. Positives anti-IgG sera were also
analysed for the presence of anti-IgM antibodies and viral RNA.
2. Methods
2.1. Study Groups
One-hundred and fifty serum samples from forestry workers were provided by "Fondazione
Edmund Mach”, Research and Innovation Centre, Department of Biodiversity and Molecular Ecology
(Trento, Italy). The samples were collected from May 2014 to January 2015 from 150 healthy males
working for the local forestry service in the Autonomous Province of Trento, the Italian Alps, Northern
Italy (6207 km2, 541,400 inhabitants, mean altitude: 700 meters above sea level (a.s.l.) and were part of
routine health checks carried out by the Provincial Health Authority [21]. The mean age was 48 years
(standard deviation SD: 7), and the median age was 49.
The study was planned for independent cases and controls with 0.6 controls per case. The true
probability of exposure in forestry workers was assumed to be 25%. To reject the null hypothesis that
the exposure rates for case and controls were equal with probability (power) 80%, at least 150 cases
and 85 controls should have been tested. The type I error probability associated with this test of this
null hypothesis was 5%.
As a control, the second group of 85 serum samples collected in 2013–2014 was obtained from
Toscana region by the serum bank of the Laboratory of Molecular Epidemiology, Department of
Molecular and Developmental Medicine, University of Siena (Central Italy). Samples were chosen in
order to reflect the age and sex composition of the forestry workers group: males with a mean age of
48 years (SD: 14) and the median age of 49. Due to the non-normal distribution of age, the comparison
between the 2 groups was performed using the Mann–Whitney U test. The results (U = 6236; p = 0.781)
indicated that there was no statistically significant difference. Concerning the sex of control and
exposed groups, both consisted of males.
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Sera were coded and anonymously collected in compliance with European data protection
regulation. The only information available was age, sex and year of sampling.
2.2. Seroprevalence of IgG Anti-HEV
For seroprevalence estimation, the commercial ELISA test by Wantai (Wantai Biological Pharmacy
Enterprise Co., Ltd, Beijing, China) was used. This assay shows specificity and sensitivity for the
HEV IgG of 97.96% and 99.6%, respectively [22,23], and was used according to the manufacturer’s
instructions.
2.3. Detection of Anti-HEV IgM Antibodies by Western Blotting
Due to budget constraints, as suggested by Spada in previous work [16], the anti-HEV IgG
prevalence of the study group being less than 15%, only the anti-HEV IgG positive sera were further
analysed for the presence of anti-HEV IgM by Western blotting (WB). The capsid protein derived from
genotype 3 swine HEV expressed by a recombinant baculovirus in Sf9 insect cells ∆111Orf2C59 was
used as antigen in WB [24].
Transferred protein was incubated with serum samples (1:100), then membranes were stained with
anti-human secondary antibodies, anti-IgM (µ-chain specific) conjugated with alkaline phosphatase
(1:5000) (Sigma, Saint Louis, MO, US). A serum derived from a naturally infected swine [25] was used
as positive control and subsequently detected with an anti-pig IgG (Sigma-Aldrich Co. St. Louis, MO,
USA), conjugated with alkaline phosphatase for staining.
2.4. Viral Extraction and Real-Time RT-PCR
Viral RNA was extracted from 100 µL of anti-IgM positive sera using the QIAamp Viral RNA Mini
Kit (Qiagen, Redwood City, CA, USA) following manufacturers’ instructions. HEV genome detection
was performed using RNA Ultrasense One-Step Quantitative RT-PCR System (Life Technologies,
Carlsbad, CA, USA) [26].
2.5. Statistical Analysis
Forestry workers were considered as a professionally exposed group. Group values were
compared using the χ2 test. A p-value ≤ 0.05 was considered statistically significant for the analyses.
A multivariable logistic regression model was carried out to determine which variables were associated
with HEV seroprevalence: age (dichotomised on the median age value, ≤ 48 versus ≥49 years),
work category (forestry workers versus control group) and their interaction. The model was based on
the simultaneous entry of all variables, and its efficacy was assessed based on the likelihood ratio and
the Hosmer–Lemeshow statistic.
The odds ratio (OR) and 95% confidence intervals (95%CI) were calculated from the final
multivariable logistic regression model.
All statistical analyses were performed using the software SPSS 25.0 (IBM SPSS Statistics, New York,
NY, USA).
3. Results
Overall, 29/235 tested sera (12.3%; 95%CI: 8.4–17.2) were positive for anti-HEV IgG. The anti-HEV
IgG seroprevalence was 14% (21/150, 95%CI: 8.9–20.6) for forestry workers and 9.4% (8/85, 95%CI:
4.2–17.7) for the control group (Table 1). The difference observed in the two groups was not
statistically significant.
Comparing the overall seroprevalence according to the median age, results showed that it increased
with age, being higher in subjects ≥ 49 years (17/119, 14.3%; 95%CI: 8.6–21.9) than in subjects ≤ 48
years (12/116, 10.3%; 95%CI: 5.5–17.4). Comparing the seroprevalence within the two study groups,
the prevalence in younger subjects (ages below the median) was higher in the control group (6/45,
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13.3%; 95%CI: 5.1–26.8) than in forestry workers (6/71, 8.5%; 95%CI: 3.2–17.5; p = 0.53). Conversely,
seroprevalence in the older subjects (with ages above the median) was higher in the forestry workers
(15/79, 19.0%; 95%CI: 11.0–29.4; p = 0.04) than in the control group (2/40, 5.0%; 95%CI: 0.6–16.9), and the
difference was statistically significant (χ2 = 4.24; p = 0.04) (Table 1).
Table 1. Anti-HEV (hepatitis E virus) IgG serum antibodies in forestry workers and control group by
median age.
Median Age Group ELISA Anti-IgG Positive/Total Prevalence (%) 95%CI p
≤48 Forestry workers 6/71 8.5 3.2–17.5
0.53Control group 6/45 13.3 5.1–26.8
Total 12/116 10.3 5.5–17.4
≥49 Forestry workers 15/79 19.0 11.0–29.4
0.04Control group 2/40 5.0 0.6–16.9
Total 17/119 14.3 8.6–21.9
Total Forestry workers 21/150 14.0 8.9–20.6
0.30Control group 8/85 9.4 4.2–17.7
Total 29/235 12.3 8.4–17.2
Multivariable logistic regression analysis was performed to evaluate possible associations between
the presence of anti-HEV antibodies, professional exposure, median age and considering both median
age and professional exposure (Table 2).
Table 2. Multiple-logistic-regression-derived relative risk (RR) and 95% confidence interval (CI) for
anti-HEV IgG in forestry workers vs control group, adjusted for median age and both variables
considered together.
Risk Factor Odds Ratio 95%CI p
Group
Forestry workers 1.67 0.50–5.53 0.40
Control group referent - -
Age
≥49 2.92 0.55–15.40 0.21
≤48 referent - -
Interaction group × age 7.42 1.06–51.81 0.04
Constant 6.50 0
No significant difference in odds ratio (OR) related to compared groups (OR = 1.67; 95%CI:
0.50–5.53) or median age (OR = 2.92; 95%CI: 0.55–15.40) was detected. However, in the multivariable
logistic regression, there was the interaction between median age and group. The OR of HEV
seroprevalence was significantly (p = 0.04) higher in old forestry workers (OR = 7.42; 95%CI: 1.06–51.81)
(Table 2).
The twenty-nine sera, tested positive by ELISA, were further analysed by WB for anti-HEV IgM
antibodies detection. Two sera gave a positive result, and they both belonged to the forestry workers’
group (2/235, 0.85%; 95%CI: 0.10–3.04).
Sera positive for both IgG and IgM were also analysed for the presence of viral RNA by One-Step
Quantitative Real-Time RT-PCR System. One serum from a forestry worker resulted positive with
a mean threshold cycle (Ct) in Real-time value of 36.6. However, no sequences were obtained from
the sample.
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4. Discussion
Studies of seroprevalence of anti-HEV IgG antibodies, conducted in general population and
control groups in Europe, have revealed a significant variability among different geographical areas,
ranging from 1.3% (Italy) to 52.5% (France) [27] and also varying within the country. The variability
may be linked to the different methods used, with a wide range of ELISA tests, which differ for the
antigens used, for sensitivity and specificity [28]. Furthermore, the anti IgG seroprevalence rate may
be affected by the local eating habits of a particular region [15,16]. For these reasons, comparing
seroprevalence data with the results of different studies is difficult to achieve.
Besides foodborne, which is considered the main route of HEV infections in Europe, other
proposed transmission routes are linked to professional exposures of subjects that are in strict and
daily contact with the zoonotic HEV reservoirs, such as pigs and other wildlife species (mainly wild
boar). In Italy, as well as in other European countries, the human cases are mainly due to HEV-3, which
is widespread in domestic pigs (prevalence 26.5–87%; up to 95% in adult pigs) [11,25] and wild boar
(prevalence up to 52.2%) [27]. In some areas of the country, the density of wild animals is managed by
hunting programs, which involve hunters and forestry workers. In particular, working duties and
amount of time spent in the forest make contact probabilities of this latter group with wildlife fauna
and their habitat higher.
In the present study, HEV exposure in a group of forestry workers was evaluated by IgG anti-HEV
detection in sera. The 14% seroprevalence observed in forestry workers was comparable to values
reported in other studies on people with occupational contacts with animals or environmental sources:
18% and 31% in forestry workers in Germany [14] and France [29], respectively, 13% in Norway
veterinaries [30], 22.2% [9] and 3.8% [31] in Polish hunters and 12.3% in Italian swine workers [11].
In Italy, previous data on blood donors have reported seroprevalence rates ranging from 8.7% to
9.8% [10,16,32], in line with the results obtained in our control group (10%).
The seroprevalence in forestry workers was 14%, which was higher than 9.4% in the control group,
and the difference was not supported by statistical analyses. This result could be biased by the limited
number of our samples and by the different geographical origin of the two groups (northern versus
central Italy). The seroprevalence in the two regions has been investigated in a national survey on
blood donor [16]. The mean seroprevalence of anti-HEV in males of Trentino-Alto Adige (the region of
forestry in this study) was 4.7%, while in the same group in Tuscany (the region of controls in this
study), it was 7.9%. Besides, the relative low difference in the mean seroprevalence between the two
regions, these values and in particular the value of seroprevalence in Tuscany is near the mean HEV
IgG seroprevalence reported in Italy (8.7%) [16].
The importance of confirming the higher risk linked to professional exposure deserves further
analyses with more samples.
One parameter associated with the higher seroprevalence is the age, as resulted by multivariable
logistic regression analyses. The odds ratio of HEV seropositivity was significantly higher in older
forestry workers (age ≥ 49). The increasing prevalence of anti-HEV IgG with age could be due to
exposure to HEV over a longer span of time [33]. Unfortunately, no information is available regarding
the number of years on the job as foresters of the subjects involved, but we can suppose that older
subjects have been working for a long time than younger. Our findings were in agreement with previous
studies, showing an increasing prevalence with age, which is likely to reflect cumulative exposure to
HEV over time [29,34] and is therefore considered a predictor of HEV IgG seropositivity [35].
On testing the sera positive in ELISA by WB, two of them were found to be positive for IgM, which
corresponded to 0.8% of seropositive. Our results agreed with precedent anti-HEV IgM seroprevalence
studies conducted in blood donors in Italy [16] and in France [36], indicating an anti-HEV IgM
prevalence of 0.4% [16] and 1%, respectively.
The risk factor of being exposed to HEV for forestry workers could be linked not only to their
duties but also to their workplace. Contact with wild animals, not only their organs [18] but also with
stools spread in the environment [37], may be the sources of HEV infection.
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Another risk factor could be the improper use or wear of personal protective equipment, which,
as demonstrated for wild boar hunters, represents a barrier to reduce the exposures to HEV while
handling infected animals [38]. Overall, further studies are needed to evaluate the risk for workers and
suggest preventive measures. Even if this study has some limitations, such as the number of samples
and the different geographical origin of the two analysed groups, it confirms previous findings of
the risk of acquiring HEV infection through occupational exposure and, in particular, the role of time
spent in a natural environment where wildlife is present. This kind of risk is yet underestimated,
especially in Italy, and therefore deserves more attention and further investigations on both human
and animal sides.
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